# Study on the Intervention Effect of Denosumab on High-Risk Patients With Osteoporotic Fractures in Type 2 Diabetes

> **NCT07063797** · NA · NOT_YET_RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 358 (estimated)

## Conditions studied

- Type 2 Diabetes
- Osteoporosis
- Fractures

## Interventions

- **DRUG:** Denosumab treatment in type 2 diabetes mellitus (T2DM) with osteoporosis patients
- **DRUG:** Denosumab combined with eldecalcitol treatment in type 2 diabetes mellitus (T2DM) with osteoporosis patients

## Key facts

- **NCT ID:** NCT07063797
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 358 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07063797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07063797, "Study on the Intervention Effect of Denosumab on High-Risk Patients With Osteoporotic Fractures in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07063797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*